The promoter for angiotensinogen (renin substrate and precursor of angiotensin II) is directly controlled by estrogen through estrogen response elements [33,34] which suggests that estrogen may modulate systolic dysfunction, HF and mortality in female mice with DCM. This evidence concerns the gene REN and hydrops fetalis.